There are more than 250,000 ovarian cancer survivors in the U.S. and this number is growing. Throughout treatment for this disease, many patients encounter serious effects, including physical issues like nausea, vomiting, fatigue, sleep disruptions, peripheral neuropathy, hair loss, and sexual dysfunction, as well as psychological challenges such as cognitive dysfunction, fear of recurrence, anxiety, and depression. Comprehensively understanding how the prevalence and severity of side effects, unmet needs, and barriers to supportive care affect quality of life in diverse ovarian cancer survivors remains a research gap and priority.